Studies recommended based on the product Label and regulatory guidance. These studies involve BE principles, Recovery studies, particle size analysis, etc., and assessing impact of other factors in BE of product while pass through Nasogastric / Gastric tubes. 

iVRS successfully submitted feeding tube studies to various regulatory authorities like Health Canada and USFDA and the studies have been approved.
Some of our feeding tube studies includes

◘ Rivaroxaban Tablets

◘ Ticagrelor Tablets

◘ Sodium Polystyrene Sulfonate Suspension

◘ Mycophenolate Mofetil Powder for Oral Suspension

◘ Osimertinib Tablets

◘ Dexlansoprazole Delayed Release Capsules